Who owns Proqr Thrapeutics N V shs euro?
- Ticker: PRQR
- CUSIP Number: n71542109
Tip: Access positions for across all investors
Analyze quarterly positions in Proqr Thrapeutics N V shs euro with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Proqr Thrapeutics N V shs euro stock
Who bought or sold Proqr Thrapeutics N V shs euro this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 6.3M | $13M | 0% | Dec 2025 |
|
| Privium Fund Management B.V. | 5.5M | $8.9M | 2% | Mar 2026 |
|
| Standard Life Aberdeen | 3.3M | $5.4M | 12% | Mar 2026 |
|
| Affinity Asset Advisors | 2.5M | $5.0M | -32% | Dec 2025 |
|
| Sio Capital Management | 2.2M | $4.4M | 4% | Dec 2025 |
|
| DAFNA Capital Management | 1.6M | $2.5M | 0% | Mar 2026 |
|
| Kynam Capital Management | 1.6M | $2.5M | 0% | Mar 2026 |
|
| Ikarian Capital | 1.5M | $2.4M | 0% | Mar 2026 |
|
| Morgan Stanley | 1.3M | $2.1M | -5% | Mar 2026 |
|
| Platinum Investment Mangement | 1.2M | $2.0M | 0% | Mar 2026 |
|
| M28 Capital Management | 1.0M | $2.1M | 0% | Dec 2025 |
|
| Two Sigma Investments | 919k | $1.5M | 9% | Mar 2026 |
|
| Point72 Asset Management | 756k | $1.2M | -7% | Mar 2026 |
|
| Citadel Advisors | 703k | $1.1M | 14% | Mar 2026 |
|
| Nomura Asset Management International | 620k | $1.0M | 100% | Mar 2026 |
|
| Walleye Trading Advisors | 608k | $984k | 3% | Mar 2026 |
|
| Monaco Asset Management SAM | 419k | $679k | -2% | Mar 2026 |
|
| Boothbay Fund Management | 355k | $576k | 0% | Mar 2026 |
|
| Raymond James Financial | 343k | $693k | 211% | Dec 2025 |
|
| UBS Group | 305k | $495k | -62% | Mar 2026 |
|
| Northern Trust | 295k | $595k | 0% | Dec 2025 |
|
| Millennium Management | 194k | $315k | -55% | Mar 2026 |
|
| Palo Alto Investors | 189k | $306k | 0% | Mar 2026 |
|
| Bank of America Corporation | 185k | $300k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 172k | $279k | 10% | Mar 2026 |
|
| Diadema Partners | 168k | $338k | 6% | Dec 2025 |
|
| Franklin Street Advisors | 150k | $243k | 0% | Mar 2026 |
|
| XTX Topco | 118k | $238k | 1057% | Dec 2025 |
|
| GSA Capital Partners | 114k | $185k | 100% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 109k | $176k | 0% | Mar 2026 |
|
| Quadrature Capital | 104k | $211k | 100% | Dec 2025 |
|
| Graham Capital Management | 92k | $148k | 100% | Mar 2026 |
|
| Resources Investment Advisors | 85k | $138k | 0% | Mar 2026 |
|
| Geode Capital Management | 85k | $138k | 0% | Mar 2026 |
|
| Lynx1 Capital Management | 69k | $111k | 0% | Mar 2026 |
|
| Persistent Asset Partners | 46k | $75k | 2% | Mar 2026 |
|
| Velan Capital Investment Management | 45k | $91k | 0% | Dec 2025 |
|
| Invesco | 45k | $72k | 76% | Mar 2026 |
|
| Simplex Trading | 44k | $89k | 100% | Dec 2025 |
|
| Jane Street | 33k | $54k | -79% | Mar 2026 |
|
| Axiom Investment Management | 33k | $54k | 100% | Mar 2026 |
|
| Squarepoint Ops | 32k | $51k | 100% | Mar 2026 |
|
| Nine Masts Capital | 30k | $48k | 100% | Mar 2026 |
|
| Guggenheim Capital, LLC Managers | 28k | $45k | 60% | Mar 2026 |
|
| Moody Lynn & Co/ | 25k | $41k | 0% | Mar 2026 |
|
| Keating Financial Advisory Services | 21k | $33k | 100% | Mar 2026 |
|
| Mariner Wealth Advisors | 20k | $33k | 5% | Mar 2026 |
|
| China Universal Asset Management | 20k | $32k | 100% | Mar 2026 |
|
| JustInvest | 19k | $31k | -13% | Mar 2026 |
|
| RFG Advisory | 19k | $31k | -37% | Mar 2026 |
|
| Group One Trading | 19k | $31k | -38% | Mar 2026 |
|
| Susquehanna International | 14k | $28k | -45% | Dec 2025 |
|
| Atom Investors | 13k | $27k | 0% | Dec 2025 |
|
| Branch Banking & Trust Company | 10k | $16k | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 10k | $16k | 0% | Mar 2026 |
|
| Nano Cap New Millennium Growth Fund | 10k | $20k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 4.0k | $6.5k | 0% | Mar 2026 |
|
| BlackRock | 3.9k | $6.4k | 0% | Mar 2026 |
|
| Hilton Head Capital Partners | 1.4k | $2.3k | 100% | Mar 2026 |
|
| Steward Partners Investment Advisory | 1.3k | $2.1k | 0% | Mar 2026 |
|
| Tower Research Capital | 1.2k | $2.4k | 36% | Dec 2025 |
|
| Farther Finance Advisors | 1.0k | $1.7k | 0% | Mar 2026 |
|
| PFS Partners | 1.0k | $1.6k | 0% | Mar 2026 |
|
| SBI Securities | 515.00 | $833.991000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 308.00 | $0 | -100% | Mar 2026 |
|
| Caitong International Asset Management | 123.00 | $199.001700 | 100% | Mar 2026 |
|
| TD Waterhouse Canada | 40.00 | $68.000000 | 0% | Mar 2026 |
|
| Medallion Wealth Advisors | 10.00 | $16.000000 | 0% | Mar 2026 |
|
Who sold out of Proqr Thrapeutics N V shs euro?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Siren | Sep 2025 | 1.6M | $3.3M |
| Arrowpoint Asset Management | Dec 2025 | 1.2M | $2.4M |
| Macquarie Group | Sep 2025 | 620k | $1.3M |
| Two Sigma Advisers | Dec 2025 | 452k | $914k |
| Fifth Third Bancorp | Dec 2025 | 30k | $61k |
| Pnc Financial Services | Dec 2025 | 20k | $41k |
| Advisor Group Holdings | Sep 2025 | 6.0k | $14k |
| Jpmorgan Chase & Co | Sep 2025 | 468.00 | $996.699600 |
| Rockefeller Capital Management | Dec 2025 | 34.00 | $68.999600 |